Peters C, Bruno A, Rizzari C, Brescianini A, von Stackelberg A, Linderkamp C, Zeng Y, Zugmaier G, Locatelli F. Blinatumomab is associated with better post-transplant outcome than chemotherapy in children with high-risk first-relapse B-cell acute lymphoblastic leukemia irrespective of the conditioning regimen. Haematologica; https://doi.org/10.3324/haematol.2024.285837 [Early view].